Background and objective: Tumor size is an important prognostic factor in cancers. This study aims at investigating the interaction between gender status and tumor size to evaluate cancer-specific survival (CSS) in hepatocellular carcinoma (HCC). Methods: In this study, we searched Surveillance, Epidemiology, and End Results (SEER) population-based data and identified 38,368 patients diagnosed with HCC between 1988 and 2012. Patients diagnosed between 1998 and 2007 were distributed into a training set (n ¼ 19279), and the rest were assigned as a SEER validation set (n ¼ 19089). Definition of cutoff value of tumor size stratified by gender was determined by the ''X-Tile'' program. The five-year CSS data were found. Long-term survival outcomes and risk factors were analyzed by the Kaplan-Meier methods and the multivariable Cox regression models. Results: There were significant differences among these different tumor size subgroups with regards to five-year CSS (p < 0.001). When applying cutoff points of 38 mm and 75 mm tumor size in men, and 38 mm and 55 mm in women, the most significant difference was observed by the X-Tile program, respectively (p < 0.001). The five-year CSS was 27.5% for women and 25.7% for men in the training set, and 33.9% for women and 31.1% for men in the validating set (p < 0.001). Further analysis showed that this significant difference existed in localized, regional, and distant-stage patients. Conclusions: These results demonstrated that women with HCC appeared to exhibit better survival rates than men. The sexrelated discrepancies should be emphasized, particularly for HCC patients with 39 to 75 mm tumors. 
Introduction
Liver cancer (including hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma as well as other rare types) was predicted to be the sixth most common malignancy and the fourth leading cause of cancer death in 2018. 1 HCC is closely associated with a history of chronic hepatitis caused by hepatitis B or C virus (HBV or HCV). [2] [3] [4] Over the last few years, trends in HCC have shown significant increases. 5 In 2013, an estimated 7920 women and 22,720 men in the United States (US) were diagnosed with primary liver cancer. 6 This malignancy displays a significant gender disparity and mainly affects men more than women. 7, 8 The male-to-female ratio averages between 2:1 and >4:1 in different analyses. 9 Recently, the role of estrogen has gained considerable attention, and it has also provided new insight into HCC development. 10 In addition, cirrhosis progress to HCC is thought to occur more frequently in men and postmenopausal women, suggesting that sex hormones might play an important role in the gender difference in the incidence of HCC. 11 Tumor size is a known independent prognostic factor for HCC. [12] [13] [14] Hence, most staging systems are based on tumor size, and increased tumor size is closely correlated with decreased cancer-specific survival (CSS). 15 In particular, tumor size correlates with survival in men and women may be different. Given the growing importance of sex-related discrepancies in tumor size, we used date from the Surveillance, Epidemiology, and End Results (SEER) program to identify the impact of gender and tumor size on HCC prognosis.
Materials and methods Patients
The SEER database provides information on 18 population-based cancer statistics in an effort to reduce the cancer burden among the US population. According to the Site Recode Classifications, we extracted cases of invasive liver cancer (C22.0) from the SEER database. These cases were diagnosed between 1988 and 2012. Then, we expanded morphology codes for liver cancer. Those patients without histological type, incomplete staging or follow-up were excluded. Meanwhile, we also assessed variables for these patients including age, race, sex, stage, histologic type, tumor grade and size, as well as CSS rates between age 18 and 85 years at diagnosis. The primary end point of the study was five-year CSS rate. We obtained access to the SEER database public data file numbered 10504-November 2014.
Statistical analyses
Data are expressed as mean AE SEM, or as absolute number or percentage for categorical variables.
We used different ways to analyze and evaluate different targets: the chi-squared ( 2 ) test for evaluating the relationship between gender categories and clinicopathological parameters, the Student t-test for comparing continuous variables, the Kaplan-Meier method for generating survival curves, the log-rank test for analyzing differences between the curves, and the Cox proportional-hazards model for assessing survival outcomes and risk factors. P values 0.05 were considered significant. All statistical analyses were performed using the statistical software package SPSS for Windows, version 17 (SPSS, Inc).
Results

Patient characteristics
In total, 19,279 eligible patients with HCC between 1988 and 2007 were enrolled. A total of 14,524 (70.9%) were men and 4755 (29.1%) were women. The median follow-up period was 29 months. Between 2008 and 2012, a total of 19,089 HCC patients were diagnosed from the SEER data and selected as a validation set. Patient demographics and pathological features are summarized in Table 1 .
Identification of cutoff points of tumor size stratified by gender
By using the X-Tile program, our results showed that the maximum chi-squared points of 2173.432 and 454.299 were achieved when applying 38 mm and 75 mm tumor size as the optimal cutoff point in men (survival rate 45.9%, 20.2% and 10.2% for patients with 0-38 mm, 39-75 mm and !76 mm tumors, respectively; p < 0.001); and 38 mm and 55 mm in women (survival rate 44.5%, 25.8% and 16.3% for patients with 0-38 mm, 39-55 mm and !56 mm tumors, respectively; p < 0.001) (Figures 1 and 2(a) ). By using the abovementioned cutoff points, we can divide the HCC patients into three subgroups in terms of five-year CSS.
Effect of gender on CSS
The five-year overall (p < 0.001) and CSS (p ¼ 0.002) rates were 19.1% and 25.7% in men; and 21.4% and 27.5% in women (Figure 3(a) ). Additionally, in men (p ¼ 0.002), univariate analysis found that larger tumor size, the widowed group, higher stage, poor/ undifferentiated tumor grade, African American race, age older than 45 years, an early year of diagnosis as well as being men were considered significant risk factors. Additionally, the following eight factors were found to be independent prognostic factors when multivariate analysis with Cox regression was performed ( 
Interaction by gender in the training set
As illustrated in Table 3 , in the male group, the HRs for hepatocellular carcinoma-specific mortality (HCSM) gradually increased with increasing tumor size (0-38 mm, HR 0.592, 95% CI 0.558-0.628, p < 0.001; 55-75 mm, HR 1.214, 95% CI 1.141-1.291, p < 0.001; ! 76 mm, HR 1.567, 95% CI 1.484-1.656, p < 0.001), as in the female group (0-38 mm, HR 0.647, 95% CI 0.584-0.718, p < 0.001; 55-75 mm, HR 1.223, 95% CI 1.096-1.364, p < 0.001; ! 76 mm, HR 1.366, 95% CI 1.236-1.510, p < 0.001). The differences were not apparent in tumors smaller than 75 mm between the male and female groups; however, in patients with !76 mm tumors, women seemed to have a lower HCSM compare with males (HR 1.567 vs 1.366).
Subgroup analysis for evaluating the effect of tumor size based on different stages
The univariate analysis showed large tumor size exhibited decreased five-year CSS rates across several subgroups. Multivariate Cox regression analyses were performed at different stages and the results showed tumor size was validated as an independent predictor of survival for localized stage (0-38 mm, HR 0.561, 95% CI 0.524-0.600; 55-75 mm, HR 1.177, 95% CI Table 4) .
Validation of outcomes
The external validation was performed in another SEER validation set. By using the optimal cutoff value, the validation patients could also be divided into three subsets in terms of five-year CSS rates (Figure 2(b) ). The five-year overall (p < 0.001) and CSS (p < 0.001) rates were 23.3% and 31.1% in men, and 27.0% and 33.9% in women (Figure 3(b) ). Multivariate analysis showed gender was an independent prognostic factor for HCC, validating that women with HCC had better survival (Table S1 ). Meanwhile, small tumor size groups also had survival benefits across several subgroups (Tables S2 and S3 ).
Discussion
Despite the prognosis of HCC patients improving recently because of advances in early diagnosis and treatment, the incidence is still increasing. 16 A more comprehensive understanding of cancer biology could increase our knowledge of HCC and individualized treatments. Regardless of predisposing factors, there is a remarkable sex disparity in HCC incidence, with a solid predominance for men. 7 Epidemiological studies showed that elevated testosterone levels in male HBsAg carriers were correlated with the increased risk of HCC. 17, 18 Meanwhile, antiandrogen agents can prevent HCC development in male rodents. 19 In addition to the tumor-promoting activity of androgen, estrogen in women seems to protect them from hepatocarcinogenesis. Postmenopausal females are at high risk of HCC, as are early-oophorectomy patients. 20 Tumor size is also a known risk factor for poor survival of HCC. 13, 21 Both the Barcelona Clinic Liver Cancer classification and the American Joint Committee on Cancer staging system include tumor size as an important variable. However, the cutoff value for tumor size varies among different staging systems and the prognostic significance of tumor size in patients with HCC is controversial.
12,14 Pawlik et al. reported that tumor size could predict vascular invasion and histologic grade. 22 However, Zhang and colleagues found tumor size did not affect long-term survival of solitary HCC without macroscopic vascular invasion. 23 Owing to the sex-related discrepancies, the application of the proper tumor size cutoff value stratified by Figure 1 . X-tile analysis of survival data from the SEER registry. X-tile analysis was done on patient data from the SEER registry, equally divided into training and validation sets. The optimal cut-point highlighted by the black circle in the left panels (A) is shown on a histogram of the entire cohort (middle panels) (B), and a Kaplan-Meier plot (right panels) (C). P values were determined by using the cutpoint defined in the training set and applying it to the validation set.
gender in HCC patients in predicting the survival rates has been a controversial issue. In this study, we analyzed the SEER data of 19,279 HCC patients and identified 38 mm and 75 mm tumor size as the optimal cutoff value in male patients, and 38 mm and 55 mm in female patients. The five-year CSS rates were 45.9%, 20.2% and 10.2% in the 0-38 mm, 39-75 mm and !76 mm tumors in men, and 44.5%, 25.8% and 16.3% in the 0-38 mm, 39-55 mm and !56 mm tumors in women. Among these patients, regardless of gender, 0-38 mm tumors always exhibited the best survival whereas !76 mm tumors had the worst survival in male and female patients, indicating that 39-75 mm tumors was essentially heterogeneous.
Meanwhile, a piecewise relationship between large tumor size and HCSM was observed. In patients with !76 mm tumors, women had a lower HCSM compared with men, which was consistent with epidemiology results that estrogen protects women from HCC. Moreover, female patients with HCC had certain clinicopathological features and prognostic factors different from those in male patients. The percentage of patients with HCC at high/moderate grade was 33.9% in men compared with 34.3% in women. In addition, the female patients also had a higher percentage of localized stage compared with males (57.5% vs 52.5%). Further subgroup analysis demonstrated that HCC patients with 0-38 mm tumors exhibited an increased five-year CSS across several subgroups. These results were further validated in another validation set. Our results might affect clinical practice. As a result of the sex-related discrepancies, patients with 39 to 75 mm tumors have different prognoses in different genders. These HCC patients should be treated with a personalized treatment strategy, especially those HCC patients with 39 to 75 mm tumors.
This population-based surveillance study also has several limitations. First, HCC predisposing factors such as hepatitis virus and steatohepatitis were not included in the SEER database. Second, despite being based on a large, multicenter study population, individual subgroups became small after stratifying by tumor size, yielding limited statistical power. Third, the SEER database is retrospective rather than prospective, which might introduce unaccounted biases and affect the analysis. Fourth, although we observed that men and women have different cutoff points of tumor size, a real and precise association between tumor size and CSS in different genders needs to be further confirmed. Despite these limitations, the SEER database provides the opportunity to analyze a large number of patients with significant follow-up, rendering our results more convincing.
In conclusion, our study demonstrated that women appeared to have better survival rates than men in HCC, which correlated with more favorable tumor characteristics. Sex-related discrepancies should be emphasized and salvage therapy should be individualized, particularly in patients with 39 to 75 mm tumors.
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